COMMUNIQUÉS West-GlobeNewswire

Military Veteran Alpine Challenge Marks Five Years of Supporting Veterans Living with Chronic Pain
10/09/2026
MONT-TREMBLANT, Québec, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nine Canadian military Veterans living with chronic pain reached the summit at Mont-Tremblant, Quebec on September 9, completing a 10-kilometre climb for the [...]
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
10/09/2026
Management to discuss FDA 510(k) submission, clinical data, and commercial progress outside the U.S. NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), [...]
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
10/09/2026
SUNNYVALE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]
Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU
10/09/2026
This New Video Explores the Daily Realities of Raising a Child with Netherton Syndrome, and Its Impact on the Whole Family ASHBURN, Va., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“ [...]
SS Innovations Provides Update on Continuing Progress and Milestones
10/09/2026
-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS [...]
Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal Cancer
10/09/2026
Preclinical results demonstrate pelareorep activity is maintained in the presence of RAS inhibition Findings support further evaluation of pelareorep’s potential to deepen and prolong responses to RAS-targeted therapy [...]
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
10/09/2026
Next-generation divalent agents show increased anticancer activity in preclinical in vitro and in vivo models CHICAGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “ [...]
Instinct Science Announces Attending, a First-of-Its-Kind Clinical AI Assistant Built Exclusively for Veterinarians
10/09/2026
Attending is the only veterinary AI assistant grounded in peer-reviewed, continually updated references, including Plumb’s Veterinary Drugs. PHILADELPHIA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Instinct Science , the [...]
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
10/09/2026
– Post-hoc analysis shows YCANTH ® drove high rates of complete clearance in molluscum contagiosum patients regardless of disease duration – WEST CHESTER, Pa., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals [...]
First Insight Corporation Welcomes Whitney Smith, LDO as Senior Sales Representative
10/09/2026
Sixteen-year eye care veteran will cover the Southeast and bring MaximEyesAI to more practices PORTLAND, Ore., Sept. 10, 2026 (GLOBE NEWSWIRE) -- First Insight Corporation, developer of the MaximEyes eye care platform, [...]
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
10/09/2026
Regulatory and quality expertise strengthens Board as Candel advances toward planned Biologics License Application (BLA) submission and potential commercial readiness NEEDHAM, Mass., Sept. 10, 2026 (GLOBE NEWSWIRE) -- [...]
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
10/09/2026
SANTA ANA, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
Alignment Health’s Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen
10/09/2026
Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt ORANGE, Calif., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Ninety percent of seniors report at least one factor affecting [...]
Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica
10/09/2026
Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative medical imaging [...]
Ethris and EIB sign €30M financing under HERA Invest to advance further clinical development of broad-spectrum nasal antiviral
10/09/2026
Funding will support Ethris in the development of its portfolio of respiratory mRNA products for chronic respiratory diseases and pandemic preparedness. EIB’s financing is backed up by DG HERA, as part of the European [...]
Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes
10/09/2026
TEL AVIV, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“ Teva ”) announced today that it successfully priced its offering of approximately $4.9 billion ( [...]
Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock
10/09/2026
ALACHUA, Fla. and TAMPA, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of [...]
Kestra Names Daniel Finney Vice President of Research & Development
10/09/2026
KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named [...]
Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies
10/09/2026
Acquisition adds NerveTape™, the 1st FDA-approved device for sutureless peripheral nerve repair, broadening Axogen’s addressable market within its focus markets Axogen’s commercial infrastructure, surgeon relationships [...]

Pages